Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Sci Rep ; 13(1): 15519, 2023 09 19.
Artículo en Inglés | MEDLINE | ID: mdl-37726292

RESUMEN

Calcific uremic arteriolopathy (CUA) is a severely morbid disease, affecting mostly dialyzed end-stage renal disease (ESRD) patients, associated with calcium deposits in the skin. Calcifications have been identified in ESRD patients without CUA, indicating that their presence is not specific to the disease. The objective of this retrospective multicenter study was to compare elastic fiber structure and skin calcifications in ESRD patients with CUA to those without CUA using innovative structural techniques. Fourteen ESRD patients with CUA were compared to 12 ESRD patients without CUA. Analyses of elastic fiber structure and skin calcifications using multiphoton microscopy followed by machine-learning analysis and field-emission scanning electron microscopy coupled with energy dispersive X-ray were performed. Elastic fibers specifically appeared fragmented in CUA. Quantitative analyses of multiphoton images showed that they were significantly straighter in ESRD patients with CUA than without CUA. Interstitial and vascular calcifications were observed in both groups of ESRD patients, but vascular calcifications specifically appeared massive and circumferential in CUA. Unlike interstitial calcifications, massive circumferential vascular calcifications and elastic fibers straightening appeared specific to CUA. The origins of such specific elastic fiber's alteration are still to be explored and may involve relationships with ischemic vascular or inflammatory processes.


Asunto(s)
Calcifilaxia , Fallo Renal Crónico , Calcificación Vascular , Humanos , Tejido Elástico , Fallo Renal Crónico/complicaciones , Márgenes de Escisión , Microscopía Electrónica de Rastreo
2.
JAMA Dermatol ; 155(7): 789-796, 2019 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-31116362

RESUMEN

Importance: Calcific uremic arteriolopathy (CUA), a rare, potentially fatal, disease with calcium deposits in skin, mostly affects patients with end-stage renal disease who are receiving dialysis. Chemical composition and structure of CUA calcifications have been poorly described. Objectives: To describe the localization and morphologic features and determine the precise chemical composition of CUA-related calcium deposits in skin, and identify any mortality-associated factors. Design, Setting, and Participants: A retrospective, multicenter cohort study was conducted at 7 French hospitals including consecutive adults diagnosed with CUA between January 1, 2006, and January 1, 2017, confirmed according to Hayashi clinical and histologic criteria. Patients with normal renal function were excluded. For comparison, 5 skin samples from patients with arteriolosclerosis and 5 others from the negative margins of skin-carcinoma resection specimens were also analyzed. Main Outcomes and Measures: Localization and morphologic features of the CUA-related cutaneous calcium deposits were assessed with optical microscopy and field-emission-scanning electron microscopy, and the chemical compositions of those deposits were evaluated with µ Fourier transform infrared spectroscopy, Raman spectroscopy, and energy dispersive radiographs. Results: Thirty-six patients (median [range] age, 64 [33-89] years; 26 [72%] female) were included, and 29 cutaneous biopsies were analyzed. Calcific uremic arteriolopathy and arteriolosclerosis skin calcifications were composed of pure calcium-phosphate apatite. Calcific uremic arteriolopathy vascular calcifications were always circumferential, found in small to medium-sized vessels, with interstitial deposits in 22 (76%) of the samples. A thrombosis, most often in noncalcified capillary lumens in the superficial dermis, was seen in 5 samples from patients with CUA. Except for calcium deposits, the vessel structure of patients with CUA appeared normal, unlike thickened arteriolosclerotic vessel walls. Twelve (33%) patients died of CUA. Conclusions and Relevance: Calcific uremic arteriolopathy-related skin calcifications were exclusively composed of pure calcium-phosphate apatite, localized circumferentially in small to medium-sized vessels and often associated with interstitial deposits, suggesting its pathogenesis differs from that of arteriolosclerosis. Although the chemical compositions of CUA and arteriolosclerosis calcifications were similar, the vessels' appearances and deposit localizations differed, suggesting different pathogenetic mechanisms.


Asunto(s)
Calcifilaxia/fisiopatología , Piel/patología , Calcificación Vascular/patología , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Calcifilaxia/diagnóstico , Calcifilaxia/etiología , Estudios de Cohortes , Femenino , Humanos , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/terapia , Masculino , Microscopía , Microscopía Electrónica de Rastreo , Persona de Mediana Edad , Diálisis Renal/métodos , Estudios Retrospectivos
3.
Am J Nephrol ; 47(4): 219-227, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29587251

RESUMEN

BACKGROUND: Pregnancy in hemodialysis (HD) women is a rare event and often associated with maternal and fetal complications. Scarcity of available data from large cohorts impedes fair medical counseling. METHODS: This is a descriptive, retrospective, multi-centric study. Pregnant women on HD during the period from 1985 to 2015 in France were included. The primary outcome was a living infant discharged from hospital, while secondary outcomes included gestational age and birth weight. RESULTS: We identified 100 pregnancies in 84 women on HD, from 41 centers. Chronic HD was initiated during pregnancy for 17.7% (14/79) of patients explaining a 19.8% prevalence of catheter (19/96) and a preserved residual diuresis for 50% of pregnancy (43/86). Seventy-six (89.4%) women performed daily dialysis during the third trimester (6 times per week). Our primary outcome was met for 78% of newborns with a mean gestational age of 33.2 ± 3.9 weeks and a mean birth weight of 1,719 ± 730 g. CONCLUSIONS: Our study is one of the largest series of -pregnancies in HD patients. Despite recent progresses, these pregnancies remain at high risk, reinforcing the need for an early nephrologist-obstetrician skilled team co-management.


Asunto(s)
Peso al Nacer , Fallo Renal Crónico/complicaciones , Complicaciones del Embarazo/epidemiología , Resultado del Embarazo/epidemiología , Adulto , Cesárea/estadística & datos numéricos , Femenino , Francia/epidemiología , Edad Gestacional , Humanos , Recién Nacido , Fallo Renal Crónico/terapia , Embarazo , Complicaciones del Embarazo/etiología , Diálisis Renal , Estudios Retrospectivos , Factores de Riesgo
4.
Am J Kidney Dis ; 71(5): 754-757, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29224958

RESUMEN

We report a case of a patient who had the mitochondrial cytopathy complex of neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome diagnosed at age 11 years with a biopsy-proven kidney involvement that progressed to end-stage renal disease at age 21 years. Mutations of mitochondrial DNA (mtDNA) are maternally inherited and lead to mitochondrial cytopathies with predominant neurologic manifestations: psychomotor retardation, epilepsy, ataxia, neuropathy, and myopathy. Given the ubiquitous nature of mitochondria, cellular dysfunction can also appear in tissues with high metabolic turnover; thus, there can be cardiac, digestive, ophthalmologic, and kidney complications. Mutations in the MT-ATP6 gene of mtDNA have been shown to cause NARP syndrome without renal involvement. We report a patient who had NARP syndrome diagnosed at age 11 years in whom glomerular proteinuria was present very early after diagnosis. Although neurologic manifestations were stable over time, he developed worsening proteinuria and kidney function. He started dialysis therapy at age 21 years. Kidney biopsy confirmed the mitochondrial cytopathy histologically, with abnormal mitochondria seen on electron microscopy. The MT-ATP6 gene mutation was detected in the kidney biopsy specimen.


Asunto(s)
Predisposición Genética a la Enfermedad , Enfermedades Renales/patología , Enfermedades Renales/terapia , Miopatías Mitocondriales/diagnóstico , Miopatías Mitocondriales/genética , ATPasas de Translocación de Protón Mitocondriales/genética , Retinitis Pigmentosa/diagnóstico , Retinitis Pigmentosa/genética , Adolescente , Ataxia/fisiopatología , Biopsia con Aguja , Niño , Progresión de la Enfermedad , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Síndrome de Kearns-Sayre/fisiopatología , Enfermedades Renales/fisiopatología , Masculino , Miopatías Mitocondriales/fisiopatología , Miopatías Mitocondriales/terapia , Enfermedades Raras , Diálisis Renal , Retinitis Pigmentosa/fisiopatología , Retinitis Pigmentosa/terapia , Resultado del Tratamiento , Adulto Joven
5.
Am J Nephrol ; 44(1): 63-70, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27400282

RESUMEN

BACKGROUND: Cystatin C is considered an alternative to creatinine to estimate glomerular filtration rate (GFR). However, studies have reported that increased adiposity is associated with a higher level of circulating cystatin C questioning the performance of estimation of GFR using cystatin C in obese subjects. METHODS: We prospectively included 166 obese stages 1-5 chronic kidney disease (CKD) patients between 2013 and 2015. GFR was measured with a reference method without (measured GFR [mGFR]) and with adjustment to body surface area (mGFRr) and estimated (eGFR) or de-indexed eGFR using the Chronic Kidney Disease and Epidemiology (CKD-EPI) equation using creatinine (CKD-EPIcreat), cystatin (CKD-EPIcyst) and the combination of cystatin and creatinine (CKD-EPIcyst-creat). RESULTS: The biases between mGFR and de-indexed CKD-EPIcyst-creat were significantly lower than de-indexed CKD-EPIcreat (p = 0.001). Accuracies were significantly better with de-indexed CKD-EPIcyst-creat compared to CKD-EPIcreat and CKD-EPIcyst, respectively (p = 0.04 and 0.03). Bland and Altman plot showed a great dispersion of all formulae when patients had a GFR >60 ml/min. Interestingly, there is a gender difference; biases, precisions and accuracies of de-indexed CKD-EPIcyst-creat were significantly lower in obese women. These results may be related to a difference in the change of body composition during obesity in men versus women and in fact only waist circumference (WC) was positively and significantly correlated with cystatin C (p < 0.0001) whereas body mass index (BMI; p = 0.3) was not; bias for CKD-EPIcyst-creat was related with WC. CONCLUSION: Cystatin C-creatinine-based GFR equations outperform creatinine-based formula in obese CKD patients especially those with BMI ≥35 and in obese women.


Asunto(s)
Creatinina/sangre , Cistatina C/sangre , Tasa de Filtración Glomerular , Obesidad/sangre , Insuficiencia Renal Crónica/sangre , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Obesidad/complicaciones , Estudios Prospectivos , Insuficiencia Renal Crónica/complicaciones , Adulto Joven
6.
J Ren Nutr ; 25(1): 31-9, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25304464

RESUMEN

OBJECTIVE: The "Pas à Pas" initiative aimed at evaluating the weekly physical activity (PA) and its determinants in a large cohort of dialysis patients. SETTING: Physical inactivity is a risk factor for mortality in maintenance dialysis patients and is still poorly documented in this population. DESIGN: A prospective national epidemiological study was performed. SUBJECTS: A total of 1,163 patients on maintenance dialysis (hemodialysis and peritoneal dialysis) were included. INTERVENTION AND MAIN OUTCOME MEASURE: PA was recorded during seven consecutive days using a pedometer to measure daily step numbers. RESULTS: Median age was 63 years (Q1 51-Q3 75). Sixty-three percent were sedentary (<5000 steps/day) with a median of 3,688 steps/day (1,866-6,271)]. PA level was similar between hemodialysis patients and those on peritoneal dialysis (3,693 steps [1,896-6,307] vs. 3,320 [1,478-5,926], P = .33). In hemodialysis patients, PA was lower on dialysis days compared with nondialysis days (2,912 [1,439-5,232] vs. 4,054 [2,136-7,108], respectively, P < .01). PA gradually decreased with age, 57% being sedentary between 50 and 65 years and 83% of patients after 80 years. Beyond this age effect, we identified, for the first time, specific phenotypes of patients with lower PA, such as inflammation, cardiovascular disease, protein energy wasting, obesity, and diabetes. By contrast, previous kidney transplantation and a higher muscle mass were associated with higher PA. CONCLUSIONS: Dialysis patients present a very low level of PA with high sedentary. Acting on patient's modifiable phenotypes may help to increase PA to improve morbidity, mortality, and quality of life.


Asunto(s)
Actividad Motora , Diálisis Peritoneal/mortalidad , Fenotipo , Diálisis Renal/mortalidad , Anciano , Índice de Masa Corporal , Enfermedades Cardiovasculares/epidemiología , Análisis por Conglomerados , Comorbilidad , Diabetes Mellitus/epidemiología , Femenino , Humanos , Inflamación/epidemiología , Trasplante de Riñón , Masculino , Persona de Mediana Edad , Estado Nutricional , Obesidad/epidemiología , Estudios Prospectivos , Desnutrición Proteico-Calórica/epidemiología , Calidad de Vida , Conducta Sedentaria
7.
Nephrol Ther ; 10(7): 485-91, 2014 Dec.
Artículo en Francés | MEDLINE | ID: mdl-25457994

RESUMEN

Pregnancy in patients presenting end-stage renal disease is rare and there are currently no recommendations for the management of these patients. In hemodialysis patients, reduced fertility and medical reluctance limit the frequency of pregnancies. Although the prognosis has significantly improved, a significant risk for unfavorable maternal (pre-eclampsia, eclampsia) and fetal (pre-term birth, intrauterine growth restriction, still death) outcome still remains. Increasing dialysis dose with the initiation of daily dialysis sessions, early adaptation of medications to limit teratogenicity and management of chronic kidney disease complications (anemia, hypertension) are required. A tight coordination between nephrologists and obstetricians remains the central pillar of the care. In peritoneal dialysis, pregnancy is also possible with modification of the exchange protocol and reducing volumes.


Asunto(s)
Fallo Renal Crónico/complicaciones , Complicaciones del Embarazo , Diálisis Renal , Femenino , Fertilidad , Humanos , Fallo Renal Crónico/epidemiología , Fallo Renal Crónico/terapia , Embarazo , Complicaciones del Embarazo/epidemiología , Pronóstico , Técnicas Reproductivas Asistidas
8.
J Immunol ; 193(7): 3398-408, 2014 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-25194054

RESUMEN

The stimulation of TLRs by pathogen-derived molecules leads to the production of proinflammatory cytokines. Because uncontrolled inflammation can be life threatening, TLR regulation is important; however, few studies have identified the signaling pathways that contribute to the modulation of TLR expression. In this study, we examined the relationship between activation and the transcriptional regulation of TLR9. We demonstrate that infection of primary human epithelial cells, B cells, and plasmacytoid dendritic cells with dsDNA viruses induces a regulatory temporary negative-feedback loop that blocks TLR9 transcription and function. TLR9 transcriptional downregulation was dependent on TLR9 signaling and was not induced by TLR5 or other NF-κB activators, such as TNF-α. Engagement of the TLR9 receptor induced the recruitment of a suppressive complex, consisting of NF-κBp65 and HDAC3, to an NF-κB cis element on the TLR9 promoter. Knockdown of HDAC3 blocked the transient suppression in which TLR9 function was restored. These results provide a framework for understanding the complex pathways involved in transcriptional regulation of TLR9, immune induction, and inflammation against viruses.


Asunto(s)
Infecciones por Virus ADN/inmunología , Virus ADN/inmunología , Regiones Promotoras Genéticas/inmunología , Receptor Toll-Like 9/inmunología , Transcripción Genética/inmunología , Animales , Infecciones por Virus ADN/genética , Infecciones por Virus ADN/patología , Células Dendríticas/inmunología , Células Dendríticas/patología , Células Epiteliales/inmunología , Células Epiteliales/patología , Femenino , Técnicas de Silenciamiento del Gen , Células HEK293 , Histona Desacetilasas/genética , Histona Desacetilasas/inmunología , Humanos , Masculino , Ratones , Células 3T3 NIH , Células Plasmáticas/inmunología , Células Plasmáticas/patología , Receptor Toll-Like 9/genética , Factor de Transcripción ReIA/genética , Factor de Transcripción ReIA/inmunología , Transcripción Genética/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...